An unusual case of linear IgA disease affecting only the oral gingiva: a case report.


Journal

BMC oral health
ISSN: 1472-6831
Titre abrégé: BMC Oral Health
Pays: England
ID NLM: 101088684

Informations de publication

Date de publication:
05 08 2023
Historique:
received: 17 10 2022
accepted: 21 07 2023
medline: 7 8 2023
pubmed: 6 8 2023
entrez: 5 8 2023
Statut: epublish

Résumé

We present a case report on desquamative gingivitis diagnosed as linear IgA disease (LAD), which is a rare autoimmune bullous disease exclusively affecting the oral gingiva. The oral mucosa can be impacted by various autoimmune bullous diseases, and our report focuses on this particular manifestation of LAD. This patient presented with atypical symptoms, as frequent blister formation on the gingiva was the primary clinical manifestation. A combination of systemic and local treatment was administered to the patient. Following the treatment, there was a significant improvement observed in both the erythema and the bullous lesions on the gingiva. A more suitable local treatment strategy should be formulated for patients presenting with oral topical lesions, which clinicians can employ effectively.

Sections du résumé

BACKGROUND
We present a case report on desquamative gingivitis diagnosed as linear IgA disease (LAD), which is a rare autoimmune bullous disease exclusively affecting the oral gingiva. The oral mucosa can be impacted by various autoimmune bullous diseases, and our report focuses on this particular manifestation of LAD.
CASE PRESENTATION
This patient presented with atypical symptoms, as frequent blister formation on the gingiva was the primary clinical manifestation. A combination of systemic and local treatment was administered to the patient. Following the treatment, there was a significant improvement observed in both the erythema and the bullous lesions on the gingiva.
CONCLUSIONS
A more suitable local treatment strategy should be formulated for patients presenting with oral topical lesions, which clinicians can employ effectively.

Identifiants

pubmed: 37543641
doi: 10.1186/s12903-023-03250-1
pii: 10.1186/s12903-023-03250-1
pmc: PMC10403837
doi:

Substances chimiques

Immunoglobulin A 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

541

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Robinson NA, Wray D. Desquamative gingivitis: a sign of mucocutaneous disorders–a review. Aust Dent J. 2003;48(4):206–11.
doi: 10.1111/j.1834-7819.2003.tb00033.x pubmed: 14738122
Gagari E, Damoulis PD. Desquamative gingivitis as a manifestation of chronic mucocutaneous disease. J Dtsch Dermatol Ges. 2011;9(3):184–8.
pubmed: 21050381
Maderal AD, Lee SPR, Jorizzo JL. Desquamative gingivitis: diagnosis and treatment. J Am Acad Dermatol. 2018;78(5):851–61.
doi: 10.1016/j.jaad.2017.04.1140 pubmed: 29678379
Hasan S. Desquamative gingivitis - a clinical sign in mucous membrane pemphigoid: report of a case and review of literature. J Pharm Bioallied Sci. 2014;6(2):122–6.
doi: 10.4103/0975-7406.129177 pubmed: 24741281 pmcid: 3983742
Hashimoto T, Yamagami J, Zone JJ. History, diagnosis, pathogenesis, and nomenclature in sublamina densa-type linear IgA disease. JAMA Dermatol. 2021;157(8):907–9.
doi: 10.1001/jamadermatol.2021.0761 pubmed: 34160568
Angiero F, Benedicenti S, Crippa R, et al. A rare case of desquamative gingivitis due to linear IgA disease: morphological and immunofluorescence features. In Vivo. 2007;21(6):1093–8.
pubmed: 18210762
Vale E, Dimatos OC, Porro AM, et al. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol. 2019;94(2 Suppl 1):48–55.
doi: 10.1590/abd1806-4841.2019940208 pubmed: 31166403 pmcid: 6544034
Challacombe SJ, Setterfield J, Shirlaw P, et al. Immunodiagnosis of pemphigus and mucous membrane pemphigoid. Acta Odontol Scand. 2001;59(4):226–34.
doi: 10.1080/00016350152509256 pubmed: 11570526
Matsumoto T, Nakamura S, Ishii N, et al. Erythrodermic linear IgA/IgG bullous dermatosis. Eur J Dermatol. 2019;29(2):220–1.
doi: 10.1684/ejd.2019.3503 pubmed: 30973330
Lally A, Chamberlain A, Allen J, et al. Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous disease. Clin Exp Dermatol. 2007;32(5):493–8.
doi: 10.1111/j.1365-2230.2007.02428.x pubmed: 17459072
Shin L, Gardner JN, Dao HJ. Updates in the diagnosis and management of linear IgA disease: a systematic review. Medicina (Kaunas). 2021;57(8):818.
doi: 10.3390/medicina57080818 pubmed: 34441024
Garcia-Pola MJ, Rodriguez-Lopez S, Fernanz-Vigil A, et al. Oral hygiene instructions and professional control as part of the treatment of desquamative gingivitis. Systematic review. Med Oral Patol Oral Cir Bucal. 2019;24(2):e136-44.
pubmed: 30818305 pmcid: 6441599

Auteurs

Jianing He (J)

Department of VIP Service Center, Stomatological Hospital, Southern Medical University, 366# Southern Jiangnan Road, Guangzhou, 510280, Guangdong, China.

Jun Shen (J)

Department of VIP Service Center, Stomatological Hospital, Southern Medical University, 366# Southern Jiangnan Road, Guangzhou, 510280, Guangdong, China. marsmare@126.com.

Wei Guo (W)

Department of Oral Pathology, Stomatological Hospital, Southern Medical University, Guangzhou, 510280, Guangdong, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH